ロード中...
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
OBJECTIVE: In an effort to account for deficiencies in axonal transport that limit the effectiveness of neurotrophic factors, this study tested the safety and feasibility, in moderately advanced Parkinson disease (PD), of bilaterally administering the gene therapy vector AAV2-neurturin (CERE-120) to...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3716474/ https://ncbi.nlm.nih.gov/pubmed/23576625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182904faa |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|